89 related articles for article (PubMed ID: 15540211)
41. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
Huang H; Li F; Gordon JR; Xiang J
Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
[TBL] [Abstract][Full Text] [Related]
42. Tumor rejection effects of allorestricted tumor peptide-specific CD4(+) T cells on human cervical cancer cell xenograft in nude mice.
Song Y; Sun W; Weng X; Liang Z; Yu Q; Wang Z; Ouyang L; Chen J; Wu X; Shen G; Wu X
Cell Transplant; 2012; 21(7):1503-14. PubMed ID: 22525838
[TBL] [Abstract][Full Text] [Related]
43. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
Feuchtinger T; Richard C; Joachim S; Scheible MH; Schumm M; Hamprecht K; Martin D; Jahn G; Handgretinger R; Lang P
J Immunother; 2008; 31(2):199-206. PubMed ID: 18481389
[TBL] [Abstract][Full Text] [Related]
44. A registry of HLA-typed donors for production of virus-specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune-compromised patients.
Li Pira G; Ivaldi F; Starc N; Landi F; Rutella S; Locatelli F; Sacchi N; Tripodi G; Manca F
Transfusion; 2014 Dec; 54(12):3145-54. PubMed ID: 25041366
[TBL] [Abstract][Full Text] [Related]
45. Development, characterization and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus 18 E7--pulsed autologous dendritic cells in a patient with metastatic adenocarcinoma of the uterine cervix.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Cowan C; Korourian S; Pecorelli S; Cannon MJ; Parham GP
Eur J Gynaecol Oncol; 2000; 21(1):17-23. PubMed ID: 10726612
[TBL] [Abstract][Full Text] [Related]
46. T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.
Steele JC; Mann CH; Rookes S; Rollason T; Murphy D; Freeth MG; Gallimore PH; Roberts S
Br J Cancer; 2005 Jul; 93(2):248-59. PubMed ID: 15986031
[TBL] [Abstract][Full Text] [Related]
47. Combining MPDL3280A with adoptive cell immunotherapy exerts better antitumor effects against cervical cancer.
Zheng Y; Yang Y; Wu S; Zhu Y; Tang X; Liu X
Bioengineered; 2017 Jul; 8(4):367-373. PubMed ID: 27754760
[TBL] [Abstract][Full Text] [Related]
48. Human papilloma virus-specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients.
McCormack SE; Cruz CRY; Wright KE; Powell AB; Lang H; Trimble C; Keller MD; Fuchs E; Bollard CM
Cytotherapy; 2018 Mar; 20(3):385-393. PubMed ID: 29331266
[TBL] [Abstract][Full Text] [Related]
49. Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.
Welters MJ; van der Sluis TC; van Meir H; Loof NM; van Ham VJ; van Duikeren S; Santegoets SJ; Arens R; de Kam ML; Cohen AF; van Poelgeest MI; Kenter GG; Kroep JR; Burggraaf J; Melief CJ; van der Burg SH
Sci Transl Med; 2016 Apr; 8(334):334ra52. PubMed ID: 27075626
[TBL] [Abstract][Full Text] [Related]
50. Gearing up T-cell immunotherapy in cervical cancer.
Chauhan SR; Bharadwaj M
Curr Probl Cancer; 2018; 42(2):175-188. PubMed ID: 29776594
[TBL] [Abstract][Full Text] [Related]
51. Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapy.
Ocadlikova D; Zahradova L; Kovarova L; Penka M; Zaloudik J; Buchler T; Hajek R; Michalek J
Med Oncol; 2006; 23(3):377-84. PubMed ID: 17018895
[TBL] [Abstract][Full Text] [Related]
52. Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.
Da Silva DM; Woodham AW; Naylor PH; Egan JE; Berinstein NL; Kast WM
J Interferon Cytokine Res; 2016 May; 36(5):291-301. PubMed ID: 26653678
[TBL] [Abstract][Full Text] [Related]
53. Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedure.
Tischer-Zimmermann S; Salzer E; Bitencourt T; Frank N; Hoffmann-Freimüller C; Stemberger J; Maecker-Kolhoff B; Blasczyk R; Witt V; Fritsch G; Paster W; Lion T; Eiz-Vesper B; Geyeregger R
Front Immunol; 2023; 14():988947. PubMed ID: 37090716
[TBL] [Abstract][Full Text] [Related]
54. Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment.
Wang W; Uberoi A; Spurgeon M; Gronski E; Majerciak V; Lobanov A; Hayes M; Loke A; Zheng ZM; Lambert PF
PLoS Pathog; 2020 Jan; 16(1):e1008206. PubMed ID: 31968015
[TBL] [Abstract][Full Text] [Related]
55. T cell-mediated help against tumors.
Wieder T; Braumüller H; Kneilling M; Pichler B; Röcken M
Cell Cycle; 2008 Oct; 7(19):2974-7. PubMed ID: 18838866
[TBL] [Abstract][Full Text] [Related]
56. Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration.
Weaver AN; Iams WT; Park JC; Mita M; Holtick U; Gordon MS; Rodabaugh KJ; Dhani N; Neupane P; Taylor M; Amanda Duvall E; Jennings J; Miselis NR; Loughhead S; Warren MS; Bernstein H; Klussmann JP; Baranda J; Jimeno A
Mol Carcinog; 2024 May; ():. PubMed ID: 38695604
[TBL] [Abstract][Full Text] [Related]
57. T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study.
Doran SL; Stevanović S; Adhikary S; Gartner JJ; Jia L; Kwong MLM; Faquin WC; Hewitt SM; Sherry RM; Yang JC; Rosenberg SA; Hinrichs CS
J Clin Oncol; 2019 Oct; 37(30):2759-2768. PubMed ID: 31408414
[TBL] [Abstract][Full Text] [Related]
58. Adaptive immunity programmes in breast cancer.
Varn FS; Mullins DW; Arias-Pulido H; Fiering S; Cheng C
Immunology; 2017 Jan; 150(1):25-34. PubMed ID: 27564847
[TBL] [Abstract][Full Text] [Related]
59. Adoptive tumour immunotherapy using human CD4+ T-cells.
Gold JE; Osband ME
Br J Cancer; 1993 Apr; 67(4):865-7. PubMed ID: 8097105
[No Abstract] [Full Text] [Related]
60. CD4
Wu K; Fong L
Trends Cancer; 2023 Oct; 9(10):777-779. PubMed ID: 37544796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
